The American Journal of Medicine
Volume 110, Issue 5 , Pages 352-360 , 1 April 2001

Efficacy and safety of combination simvastatin and colesevelam in patients with primary hypercholesterolemia

  • Howard H Knapp, MD, PhD

      Affiliations

    • Lipid Research Clinic (HHK, HS), University of Iowa, Iowa City, Iowa, USA
    • ,
  • Helmut Schrott, MD

      Affiliations

    • Lipid Research Clinic (HHK, HS), University of Iowa, Iowa City, Iowa, USA
    • ,
  • Patrick Ma, MD

      Affiliations

    • Bridgeland Medical (PM), Calgary, Alberta, Canada
    • ,
  • Robert Knopp, MD

      Affiliations

    • Northwest Lipid Research Center (RK), Seattle, Washington, USA
    • ,
  • Bruce Chin, MD

      Affiliations

    • Long Island Jewish Medical Center (BC), Manhasset, New York, New York, USA
    • ,
  • J.Michael Gaziano, MD

      Affiliations

    • VA Boston Healthcare System and Brigham and Women’s Hospital (JMG), Boston, Massachusetts, USA
    • ,
  • Joanne M Donovan, MD, PhD

      Affiliations

    • GelTex Pharmaceuticals, Inc. (JMD, SKB), Waltham, Massachusetts, USA
    • Corresponding Author InformationRequests for reprints should be addressed to Joanne M. Donovan, MD, PhD, GelTex Pharmaceuticals, Inc., 153 Second Avenue, Waltham, Massachusetts 02451
    • ,
  • Steven K Burke, MD

      Affiliations

    • GelTex Pharmaceuticals, Inc. (JMD, SKB), Waltham, Massachusetts, USA
    • ,
  • Michael H Davidson, MD

      Affiliations

    • Chicago Center for Clinical Research (MHD), Chicago, Illinois, USA

Received 17 August 2000 ,Revised 11 December 2000 ,Accepted 11 December 2000.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Funded by GelTex Pharmaceuticals, Inc., Waltham, Massachusetts.

PII: S0002-9343(01)00638-6

The American Journal of Medicine
Volume 110, Issue 5 , Pages 352-360 , 1 April 2001

Article Tools

* Image Usage & Resolution